US20230145499A1 - Method for detecting l-serine based on escherichia coli cysteine desulfurase - Google Patents
Method for detecting l-serine based on escherichia coli cysteine desulfurase Download PDFInfo
- Publication number
- US20230145499A1 US20230145499A1 US17/814,443 US202217814443A US2023145499A1 US 20230145499 A1 US20230145499 A1 US 20230145499A1 US 202217814443 A US202217814443 A US 202217814443A US 2023145499 A1 US2023145499 A1 US 2023145499A1
- Authority
- US
- United States
- Prior art keywords
- serine
- detecting
- escherichia coli
- cysteine desulfurase
- unknown sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 title claims abstract description 146
- 238000000034 method Methods 0.000 title claims abstract description 43
- 101900070042 Escherichia coli Cysteine desulfurase Proteins 0.000 title claims abstract description 14
- 229960001153 serine Drugs 0.000 claims abstract description 72
- 150000001413 amino acids Chemical class 0.000 claims abstract description 16
- 239000000126 substance Substances 0.000 claims abstract description 15
- 238000006243 chemical reaction Methods 0.000 claims abstract description 10
- 238000000338 in vitro Methods 0.000 claims abstract description 4
- 238000002835 absorbance Methods 0.000 claims description 16
- 239000012086 standard solution Substances 0.000 claims description 12
- 230000035484 reaction time Effects 0.000 claims description 4
- 241000588724 Escherichia coli Species 0.000 abstract description 19
- 108091000099 cysteine desulfurase Proteins 0.000 abstract description 16
- 102000030626 cysteine desulfurase Human genes 0.000 abstract description 16
- 238000001514 detection method Methods 0.000 abstract description 16
- 229940024606 amino acid Drugs 0.000 abstract description 12
- 235000001014 amino acid Nutrition 0.000 abstract description 12
- 239000011535 reaction buffer Substances 0.000 description 10
- 238000006911 enzymatic reaction Methods 0.000 description 7
- 238000011534 incubation Methods 0.000 description 7
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000002798 spectrophotometry method Methods 0.000 description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- DYDCUQKUCUHJBH-UHFFFAOYSA-N D-Cycloserine Natural products NC1CONC1=O DYDCUQKUCUHJBH-UHFFFAOYSA-N 0.000 description 3
- DYDCUQKUCUHJBH-UWTATZPHSA-N D-Cycloserine Chemical compound N[C@@H]1CONC1=O DYDCUQKUCUHJBH-UWTATZPHSA-N 0.000 description 3
- MTCFGRXMJLQNBG-UWTATZPHSA-N D-Serine Chemical compound OC[C@@H](N)C(O)=O MTCFGRXMJLQNBG-UWTATZPHSA-N 0.000 description 3
- 229930195711 D-Serine Natural products 0.000 description 3
- 150000008575 L-amino acids Chemical class 0.000 description 3
- 235000013878 L-cysteine Nutrition 0.000 description 3
- 239000004201 L-cysteine Substances 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 229960003077 cycloserine Drugs 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 101710110506 Cysteine desulfurase 1 Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241000665848 Isca Species 0.000 description 2
- 239000006137 Luria-Bertani broth Substances 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 description 2
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 238000013207 serial dilution Methods 0.000 description 2
- 150000003354 serine derivatives Chemical class 0.000 description 2
- 150000003355 serines Chemical class 0.000 description 2
- YPWSLBHSMIKTPR-UHFFFAOYSA-N Cystathionine Natural products OC(=O)C(N)CCSSCC(N)C(O)=O YPWSLBHSMIKTPR-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 1
- ILRYLPWNYFXEMH-UHFFFAOYSA-N D-cystathionine Natural products OC(=O)C(N)CCSCC(N)C(O)=O ILRYLPWNYFXEMH-UHFFFAOYSA-N 0.000 description 1
- MBMLMWLHJBBADN-UHFFFAOYSA-N Ferrous sulfide Chemical class [Fe]=S MBMLMWLHJBBADN-UHFFFAOYSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-UWTATZPHSA-N L-Alanine Natural products C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 102000004317 Lyases Human genes 0.000 description 1
- 108090000856 Lyases Proteins 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000008436 biogenesis Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000005251 capillar electrophoresis Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 230000003832 immune regulation Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000004811 liquid chromatography Methods 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 235000020939 nutritional additive Nutrition 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 150000003212 purines Chemical class 0.000 description 1
- 235000007682 pyridoxal 5'-phosphate Nutrition 0.000 description 1
- 239000011589 pyridoxal 5'-phosphate Substances 0.000 description 1
- 229960001327 pyridoxal phosphate Drugs 0.000 description 1
- 150000003230 pyrimidines Chemical class 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000036632 reaction speed Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 108010060800 serine-pyruvate aminotransferase Proteins 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000000439 tumor marker Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/48—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y208/00—Transferases transferring sulfur-containing groups (2.8)
- C12Y208/01—Sulfurtransferases (2.8.1)
- C12Y208/01007—Cysteine desulfurase (2.8.1.7)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/13—Transferases (2.) transferring sulfur containing groups (2.8)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6806—Determination of free amino acids
- G01N33/6812—Assays for specific amino acids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/91—Transferases (2.)
- G01N2333/91194—Transferases (2.) transferring sulfur containing groups (2.8)
Definitions
- sequencelisting.xml Size: 2,363 bytes; and Date of Creation: Jul. 7, 2022
- Date of Creation Jul. 7, 2022
- the present disclosure relates to the technical field of amino acid detection, in particular to a method for detecting L-serine based on Escherichia coli cysteine desulfurase.
- L-serine is a non-essential polar amino acid in the human body. It is mainly involved in the biosynthesis of proteins in the body. It is also an important precursor of purines, pyrimidines, and phospholipids. It plays an important role in immune regulation, tumor metabolism and other processes, and is expected to serve as a tumor marker of some cancers.
- L-serine is widely used in amino acid infusions and nutritional additives, and its derivatives also have excellent medicinal value and biological activity.
- L-serine is extensively added to high-grade cosmetics due to its wettability and moisture retention. With the in-depth research and understanding of L-serine and the continuous development of medical and health care, the demand for L-serine is also increasing.
- Instrumental methods usually include HPLC, GC-MS, LC-MS, NMR, and automatic amino acid analyzer.
- the chromogenic methods include chromotropic acid-spectrophotometry, paper chromatography-spectrophotometry, and ninhydrin method.
- Chemiluminescence method is mainly capillary electrophoresis coupling with electrochemiluminescence.
- Enzymatic methods include serine aminotransferase method and cystathionine lyase method.
- ninhydrin method is easy to operate and quick to react, but it has high requirements on reaction conditions, and requires precise control of reaction temperature, pH, and time.
- the method has different sensitivities to different types of amino acids and is not suitable for analysis of samples that require high precision. Fluorescence quenching method can avoid the interference of most amino acids, but the sample needs to undergo complex phosphorylation pretreatment, and the detection result has a large error.
- Chromotropic acid-spectrophotometry has fast reaction speed, simple operation, and high accuracy, but poor anti-interference ability.
- Enzymatic methods have excellent specificity and accuracy, but the currently used enzymatic methods have many reaction steps and many factors that affect the determination, and the detection signal often cannot be directly observed or directly measured. Therefore, it is very necessary to develop an enzymatic method for determining L-serine which is simple and can be directly observed with the naked eye after the reaction.
- An objective of the present disclosure is to provide a method for detecting L-serine based on E . coli cysteine desulfurase.
- the method is simple and feasible in technical operation, few in reaction steps, and capable of directly qualitatively detecting by naked eyes and quantitatively detecting the L-serine content.
- the present disclosure provides the following solution:
- the present disclosure provides a method for detecting L-serine based on E . coli cysteine desulfurase, including the steps of: reacting an unknown sample containing L-serine with E. coli cysteine desulfurase in vitro to produce a red substance, and qualitatively or quantitatively determining L-serine content in the unknown sample by observing a color of the red substance or determining content thereof.
- a method for qualitatively detecting the L-serine content in the unknown sample may be implemented by: observing whether a stable red substance is produced after the reaction, and a color depth of the red substance with the naked eye, and qualitatively determining the presence or absence of the L-serine in the unknown sample and the content thereof.
- a method for quantitatively detecting the L-serine content in the unknown sample may include:
- both the absorbance of the L-serine standard solution and the absorbance of the red substance may be measured at a wavelength of 528 nm.
- the E . coli cysteine desulfurase may have an amino acid sequence shown in SEQ ID NO: 1.
- the unknown sample and the E . coli cysteine desulfurase may be mixed and reacted in equal volumes.
- a reaction time may be 60-180 min.
- the E . coli cysteine desulfurase takes L-cysteine as a substrate to catalyze the generation of L-alanine and elemental sulfur, and the purified cysteine desulfurase binds to the prosthetic group pyridoxal phosphate, it appears yellow with the naked eye, and there is a characteristic absorption peak at 395 nm when scanned by a UV-Vis spectrophotometer. According to the inventor’s previous research, it is easy to know that the enzyme is expressed in an IscA - /SufA - double-deficient bacterium.
- the enzyme turns red when observed with the naked eye, and there is a stable characteristic absorption peak at 528 nm when scanned by the UV-Vis spectrophotometer.
- a stable red substance may also be generated by in vitro reaction of IscA - /SufA - double-deficient E . coli -derived cysteine desulfurase with the L-serine, and specificity thereof depends on the L-serine. More importantly, the depth of the red color, the level of the absorption peak at 528 nm, and the L-serine added in the reaction mixture are dose-dependent, thus realizing the qualitative and quantitative determination of the L-serine in an unknown sample.
- the detection method provided by the present disclosure features convenient technical operation and few reaction steps. Not only can the detection method achieve intuitive qualitative detection and precise quantification, but also can effectively prevent the interference of D-serine, cycloserine, serine analogs and other amino acids, providing a scientific method for the rapid detection of L-serine in different fields.
- FIG. 1 is an illustrative diagram of qualitative and semi-quantitative determination of L-serine and a standard colorimetric card
- FIG. 2 illustrates optimization of incubation time and establishment of a standard curve
- A effects of incubation time and wavelength on enzymatic reaction
- B screening of optimal incubation time
- C standard curve.
- test methods used in the following examples are conventional, unless otherwise specified; the materials and reagents used are commercially available reagents and materials, unless otherwise specified.
- E . coli cysteine desulfurase used in the following examples has an amino acid sequence shown in SEQ ID NO: 1:
- Reaction buffer 40 mM Tris-HCl buffer (pH 9.0), 100 ⁇ M E . coli cysteine desulfurase, and 0.4 mM L-cysteine;
- the L-serine standard solution was diluted to five concentrations, respectively: A: 0.00 mM, B: 0.25 mM, C: 0.50 mM, D: 1.00 mM, E: 2.00 mM.
- Each serial dilution of the standard solution and the unknown sample (100 ⁇ L) were each mixed with 100 ⁇ L of reaction buffer, incubated at room temperature (25° C.) for 2 h, observed with the naked eye, and photographed, and a standard colorimetric card was established.
- Reaction buffer 40 mM Tris-HCl buffer (pH 9.0), 100 ⁇ M E . coli cysteine desulfurase, and 0.4 mM L-cysteine.
- L-serine to be tested was mixed with the reaction buffer in equal volumes, and incubated at 25° C. for different times; the absorbance was measured at a wavelength of 528 nm; a curve was plotted with the time as the horizontal axis and the absorbance value at 528 nm as the longitudinal axis.
- the L-serine standard solution was diluted to three concentrations, respectively: 0.50 mM, 1.00 mM, and 2.00 mM. Each serial dilution of the standard solution and the unknown sample (100 ⁇ L) were each mixed with 100 ⁇ L of reaction buffer, incubated at room temperature (25° C.) for 2 h, and the absorbance at 528 nm was measured for sample and standard tubes, respectively.
- a standard curve was plotted with the concentration of the standard solution as the abscissa and the absorbance measured at a wavelength of 528 nm as the ordinate, and the curve was fitted to obtain a curve equation and an R 2 value.
- the L-serine concentration was obtained according to the standard curve equation obtained above and the absorbance value of the sample tube.
- each of L-serine and other L-amino acids (4 mM) to be tested were mixed with 500 ⁇ L of E . coli cysteine desulfurase, respectively, and incubated on a shaker at 37° C. and 250 rpm for 2 h, and the color depth was observed with the naked eye and photographed.
- IscA - /sufA - double mutant strain (for the construction method, refer to the master’s thesis “Functions of IscA and SufA in the Biogenesis of Iron-Sulfur Clusters in Escherichia coli ” from TONG Zhenzhen) and control wild-type E . coli MC4100 were cultured in LB broth at 250 rpm (round per minute) and 37° C. overnight, and the bacterial suspension cultured overnight was diluted 1:50 into Erlenmeyer flasks containing 500 mL of freshly prepared LB broth, respectively; the culture was continued under the same conditions until the OD 600 nm reached 0.6 (logarithmic growth phase), and the bacteria were harvested by centrifugation.
- E . coli cells were sampled, 50 mL of pre-cooled methanol/acetonitrile/water (2:2:1, v/v/v) was added to each sample, vortexed to mix, sonicated in an ice bath for 20 min, and incubated at -20° C. for 1 h to precipitate the protein; the protein was centrifuged at 14,000 rpm and 4° C. for 20 min, and the supernatant was collected and dried in vacuum. During detection, 100 ⁇ L of buffer (40 mM Tris-HCl, pH 9.0) was added to reconstitute, centrifuged at 14,000 rcf and 4° C. for 20 min, and the supernatant was collected.
- buffer 40 mM Tris-HCl, pH 9.0
- step 2 The supernatant in step 2 and L-serine standard were taken and incubated with the reaction buffer for 2 h, respectively; pictures were taken and the absorbance at 528 nm was measured; a standard curve was plotted, and the sample concentration was calculated.
- the extract of wild-type MC4100 turned pale pink after reacting with the reaction buffer (compared with the colorimetric card, it was judged that the L-serine concentration was between 0.00 and 0.25 mM), and the extract of the iscA - /sufA - double mutant strain turned dark pink after reacting with the reaction buffer (compared with the colorimetric card, it was judged that the L-serine concentration was between 0.50 and 1 mM); as calculated by quantitative determination, the L-serine content in the extract of the wild-type MC4100 was 0.21 mM. The L-serine content of the extract of the iscA - /sufA - double mutant strain was 0.53 mM. It can be seen that the results of the two methods are consistent.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- General Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202111282894.4A CN113801914B (zh) | 2021-11-01 | 2021-11-01 | 基于大肠杆菌半胱氨酸脱硫酶检测l-丝氨酸的方法 |
CN202111282894.4 | 2021-11-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
US20230145499A1 true US20230145499A1 (en) | 2023-05-11 |
US12024736B2 US12024736B2 (en) | 2024-07-02 |
Family
ID=78898524
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/814,443 Active US12024736B2 (en) | 2021-11-01 | 2022-07-22 | Method for detecting l-serine based on Escherichia coli cysteine desulfurase |
Country Status (2)
Country | Link |
---|---|
US (1) | US12024736B2 (zh) |
CN (1) | CN113801914B (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20230159980A1 (en) * | 2021-11-01 | 2023-05-25 | Wenzhou Medical University | Method for detecting l-serine based on cysteine desulfurase-containing living escherichia coli cell |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20230159980A1 (en) * | 2021-11-01 | 2023-05-25 | Wenzhou Medical University | Method for detecting l-serine based on cysteine desulfurase-containing living escherichia coli cell |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5985540A (en) * | 1997-07-24 | 1999-11-16 | Anticancer, Inc. | High specificity homocysteine assays for biological samples |
KR102281363B1 (ko) * | 2021-01-26 | 2021-07-22 | 씨제이제일제당 (주) | 신규한 시스테인 설피네이트 디설피나제 변이체 및 이를 이용한 l-발린 생산 방법 |
CN112877345B (zh) * | 2021-01-29 | 2022-05-27 | 中南大学湘雅三医院 | 一种半胱氨酸脱硫酶tp0614的基因及其重组蛋白与应用 |
-
2021
- 2021-11-01 CN CN202111282894.4A patent/CN113801914B/zh active Active
-
2022
- 2022-07-22 US US17/814,443 patent/US12024736B2/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20230159980A1 (en) * | 2021-11-01 | 2023-05-25 | Wenzhou Medical University | Method for detecting l-serine based on cysteine desulfurase-containing living escherichia coli cell |
Non-Patent Citations (4)
Title |
---|
Binkley F., J. Biol. Chem., 1943, 150, 261-262 (Year: 1943) * |
Das et al. Antioxidants, 2021, 10, 997, 1-27 (Year: 2021) * |
Duan et al. J. Antimicrob. Chemother., 2016, 71, 2192-2199 (Year: 2016) * |
Yoshida et el. Analytical Biochemistry, 1993, 208, 296-299 (Year: 1993) * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20230159980A1 (en) * | 2021-11-01 | 2023-05-25 | Wenzhou Medical University | Method for detecting l-serine based on cysteine desulfurase-containing living escherichia coli cell |
US11859236B2 (en) * | 2021-11-01 | 2024-01-02 | Wenzhou Medical University | Method for detecting L-serine based on cysteine desulfurase-containing living Escherichia coli cell |
Also Published As
Publication number | Publication date |
---|---|
US12024736B2 (en) | 2024-07-02 |
CN113801914B (zh) | 2023-02-24 |
CN113801914A (zh) | 2021-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Reddy et al. | A simplified method for the analysis of hydroxyproline in biological tissues | |
CN108484622B (zh) | 多信号荧光探针的合成及其同时区分检测Hcy、Cys和GSH的应用 | |
WO2003040694A2 (en) | Enzymatic cycling assays for homocysteine and cystathionine | |
US12024736B2 (en) | Method for detecting l-serine based on Escherichia coli cysteine desulfurase | |
CN111307789B (zh) | 一种叶酸检测试剂盒及检测方法 | |
US11859236B2 (en) | Method for detecting L-serine based on cysteine desulfurase-containing living Escherichia coli cell | |
Karp et al. | Simultaneous extraction and combined bioluminescent assay of NAD+ and NADH | |
US4080265A (en) | Method for the determination of creative phosphokinase enzyme | |
US4969741A (en) | Measurement of solid particle concentration in presence of a second particle type | |
Taylor et al. | PTEN and myotubularins: families of phosphoinositide phosphatases | |
CN110964044B (zh) | 一种基于双香豆素衍生物的过氧化亚硝酸盐荧光探针、制备方法与应用 | |
Ignatov et al. | Acrylamide and acrylic acid determination using respiratory activity of microbial cells | |
CN110398586B (zh) | 果糖胺测定试剂盒 | |
CN112461975A (zh) | 一种饲料添加剂中辅酶含量检测方法 | |
CN118169094B (zh) | 一种共混溶液在检测四环素浓度上的应用及其检测方法 | |
Jani et al. | Process analysis of macrotetrolide biosynthesis during fermentation by means of direct infusion LC‐MS | |
Ploux | Biotin | |
Kamruzzaman et al. | Spectroscopic study of the interaction between adenosine disodium triphosphate and gatifloxacin–Al3+ complex and its analytical application | |
Pitkänen et al. | A quantitative fluorometric micromethod used for the neonatal screening of biotinidase deficiency in Finland | |
SU1041568A1 (ru) | Реагент дл определени аденозин-5-трифосфата | |
CN116559129A (zh) | 基于单链dna金纳米簇的荧光传感法检测维生素b1的方法 | |
SU940020A1 (ru) | Способ определени глюкозы | |
RU2252963C1 (ru) | Способ получения иммобилизованного многокомпонентного реагента для биолюминесцентного анализа | |
JPS63219399A (ja) | フエニルアラニン又はフエニルピルビン酸定量用試薬 | |
WO2022186807A2 (en) | Spectrophotometric analysis method for determination and tracking of phenylanaine in blood |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: WENZHOU MEDICAL UNIVERSITY, CHINA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:TAN, GUOQIANG;LI, JIANGHUI;LIANG, FENG;AND OTHERS;REEL/FRAME:060598/0927 Effective date: 20220607 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE AFTER FINAL ACTION FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NOTICE OF ALLOWANCE MAILED -- APPLICATION RECEIVED IN OFFICE OF PUBLICATIONS |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: PUBLICATIONS -- ISSUE FEE PAYMENT VERIFIED |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |